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Longer duration of epilepsy and earlier age at epilepsy onset correlate with impaired 
cognitive development in infancy 
Martina Vendrame, Andreas V. Alexopoulos, Katrina Boyer, Matt Gregas, Jennifer Haut, 
Tara Lineweaver, Elaine Wyllie, Tobias Loddenkemper 
Abstract 
We assessed the impact of age at onset of epilepsy and duration and frequency of seizures on cognitive 
development in children less than 3 years old. Retrospective analysis was conducted on clinical data and 
neuropsychological testing of 33 infants with epilepsy. Developmental quotients were calculated and 
were correlated with age at epilepsy onset, duration of epilepsy, seizure frequency, brain pathology, and 
types of seizures (with/without spasms) as potential predictors. Infants with longer duration and earlier 
onset of epilepsy performed worse on developmental neuropsychological testing. Regression analyses 
showed that age at epilepsy onset and percentage of life with epilepsy were both strongly associated 
(regression model P < 0.0001) with developmental quotient. There was no correlation with seizure 
frequency. Infants with spasms had worse developmental quotients than infants without spasms 
(P < 0.001). These results suggest that duration of epilepsy and age at onset may be the best 
developmental predictors during the first years of life in patients with epilepsy. Early aggressive 
intervention should be considered. 
1. Introduction 
It is well recognized that epilepsy may contribute to cognitive impairment in children and adults. 
Most studies have provided proof that intellectual decline during childhood epilepsy is 
progressive and may be related to the duration of epilepsy, overall frequency of seizures, and age 
at epilepsy onset [1], [2] and [3]. 
 Despite this, almost no information is available regarding cognitive development of 
children <3 years old in relation to duration of epilepsy and seizure burden. The limited evidence 
that does exist in this age group is derived from longitudinal studies assessing postinterventional 
neuropsychological outcome in infants with West syndrome [4], [5], [6], [7], [8], [9], [10], [11], 
[12] and [13] and other epilepsies [5], [6], [7], [10], [11] and [14] (Table 1). Most of these 
studies have suggested that earlier surgical or medical therapy during infancy may provide 
higher benefit for intellectual development of children. Seizure freedom may be associated with 
better mental development [4], [10], [11], [12], [13] and [14]. However, none of these studies 
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have evaluated the effect of epilepsy in terms of duration and seizure burden on cognition during 
infancy. The current study expands our previous results on neuropsychological outcome in 
infants [11] and [15]. 
 Our aim was to evaluate the impact of age at onset and duration and frequency of seizures 
on the cognitive development of infants (<3 years of age) and to identify the strongest predictors 
of developmental outcome. This article describes the experience with infancy epilepsy and 
neuropsychological testing at the Cleveland Clinic and Children’s Hospital Boston from 1990 to 
2008. 
2. Methods 
Among all consecutive pediatric patients with epilepsy who underwent neuropsychological 
testing at the Cleveland Clinic and Children’s Hospital Boston between 1990 and 2008, those 
<3 years old were identified. Of the 59 patients identified, we conducted a retrospective analysis 
of clinical data and neuropsychological testing (Bayley Scales of Development) [16] of the 33 
infants with complete data. Clinical evaluation included EEG monitoring and MRI. Seizures 
were classified according to the semiological seizure classification [17]. A developmental 
quotient was calculated for each case (DQ = Bayley Scales of Infant Development mental age 
divided by subject’s biological age) as previously described [11]. Charts were reviewed 
retrospectively for DQ testing, age at epilepsy onset, duration of epilepsy, seizure frequency, 
types of seizures (with/without spasms), and etiology of seizures (with/without malformations of 
cortical development [MCD]). MCD included cases of focal cortical dysplasia, lissencephaly, 
and polymicrogyria. MCD were thought to be the cause of epilepsy in these patients as 
evidenced by correlation with video/EEG findings. 
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 We used standard regression models to assess the associations between DQ and the 
following predictors: age at epilepsy onset, age (in months), duration of life with epilepsy (in 
months), percentage of life with epilepsy [18], seizure frequency, lifetime seizures, presence of 
MCD, and presence of spasms. All terms were initially included in the model, and decisions to 
reject terms as statistically extraneous were made using likelihood ratio tests and Akiake’s 
information criterion (AIC). 
3. Results 
3.1. Descriptives 
Thirty-three infants (21 boys) with complete data and formal neurodevelopmental evaluation 
were identified among 59 consecutive patients <3 years of age. Twenty-six were excluded 
because of incomplete data. Table 2 summarizes the demographic characteristics of the sample. 
Infants were 3 to 33 months old at the time of neuropsychological testing (average = 15.6, 
SD = 9.7). Nineteen infants presented with MCD (59.4%), and 13 had epileptic spasms (39%). 
The average DQ was 0.37 (SD = 0.29), and the average age at epilepsy onset was 4 months 
(SD = 5.12). Duration of epilepsy spanned 1.5 to 32 months (average = 11.6, SD = 7.5). 
Additional information on seizures and seizure frequency is outlined in Table 2. 
3.2. Regression analysis 
The results of the regression analysis determined that either percentage of life with epilepsy or 
age at epilepsy onset was associated with or predictive of DQ. All other predictors, such as 
seizure frequency, type of brain pathology, and type of seizures, added no additional information 
once age at epilepsy onset or percentage of life with epilepsy was accounted for in the model. 
 Highly significant associations were found in the model with age at epilepsy onset as the 
only predictor of DQ (P < 0.0001), as well as in the model with percentage of life with epilepsy 
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as the sole predictor (P < 0.0001) ( Table 3). In the model with both age at epilepsy onset and 
percentage of life with epilepsy as predictors, neither term was significant. This is explained by 
the high degree of colinearity between age at epilepsy onset and percentage of life with epilepsy 
(Pearson’s correlation coefficient = −0.85). Both predictors therefore carry the same information 
about DQ, and the regression methods show that only one of these two variables is needed. 
 The direction of the regression coefficient indicates that DQ rises with increasing age at 
epilepsy onset and with decreasing percentage of life with epilepsy (Fig. 1). The model with age 
at epilepsy onset as the only predictor was a slightly better fit (as determined with Akiake’s 
information criterion) than the model with percentage of life with epilepsy as the only predictor. 
Age at epilepsy onset therefore predicts developmental outcome better than percentage of life 
with seizures. 
 Infants with spasms had a significantly lower DQ (average DQ = 0.19) than infants 
without spasms (average DQ = 0.47) (P = 0.01). In contrast, the DQ of infants with MCD did not 
differ significantly from the DQ of infants without MCD (average DQ = 0.39 and 0.37, 
respectively). No other significant associations were found between seizure frequency, total 
lifetime number of seizures, presence of MCD, and presence of spasms. 
4. Discussion 
We describe neuropsychological outcome in infants <3 years of age with epilepsy in relation to 
age at onset, duration and frequency of seizures, presence or absence of infantile spasms, and 
underlying etiology of seizures. Lower DQ is associated with earlier onset of epilepsy or with 
having epilepsy for a greater portion of one’s lifetime. Because of the large degree of colinearity 
between the two predictors, a larger data set is needed to clarify further interrelations between 
these two factors. 
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 Infants with longer duration of epilepsy and with earlier onset of epilepsy performed 
worse on developmental neuropsychological testing during the first 3 years of life. Several 
studies have observed that children with epilepsy who have progressive cognitive deterioration 
are those affected by poorly controlled epilepsy and/or earlier onset of seizures [1] and [2]. Of 
those factors, early age at epilepsy onset has been found to be the best predictor of poor 
prognosis [1]. 
 Other studies have attempted to demonstrate that most cognitive change takes place early 
in the course of epilepsy based on a critical period of learning and development as well as greater 
plasticity. Meinardi et al. [3] described a cascadic model of deterioration, in which irreversible 
developmental regression occurs shortly after the onset of seizures while later intellectual 
function plateaus, and no changes may be reported on cognitive testing. These findings could 
explain previous longitudinal studies that have somehow challenged the notion of intellectual 
deterioration in epilepsy by showing that epilepsy is associated with an early impaired 
intellectual function but little further deterioration [1], [2], [19] and [20]. Neyens et al. [21] have 
shown that children between the ages of 6 and 12 with the longest duration of epilepsy had 
smaller gains in IQ scores when compared with age-matched controls, and those who had 
epilepsy for no more than 2 years showed an even more modest gain in IQ, supporting the 
hypothesis that intellectual deterioration likely occurs early in the course of epilepsy. Another 
consideration is that epilepsy may lead to decreased plasticity. 
 Longitudinal studies assessing mental development in infants (children <3 years of age) 
with epilepsy are lacking (Table 1). Few available reports have evaluated the intellectual 
outcome in infants who have undergone epilepsy surgery [4], [11], [13] and [14]. According to 
results presented by Daniel et al., neuropsychological performance after surgery was best for 
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children who underwent surgery at a younger age. Furthermore, increase in DQ after surgery was 
most prominent in patients undergoing surgery before 12 months of age [11]. The benefit of 
earlier surgical intervention may be explained by the interruption of intellectual deterioration, 
improvement in epileptic encephalopathy, and possibly related increased plasticity. 
 In our series of patients, infantile spasms were associated with developmental delay. 
Others have shown that control of infantile spasms is associated with better development during 
infancy and childhood [4], [6], [10], [12], [22], [23], [24] and [25]. In a previous report [11], 
more frequent spasms in children undergoing early surgical intervention were documented. 
Infantile spasms usually occur during initial stages of epilepsy and, therefore, may be, at that 
stage, an indicator of severe future developmental compromise. Our results indicate that the 
presence of infantile spasms at presentation should urge prompt medical and perhaps surgical 
intervention. To this effect, Asarnow et al. [4] demonstrated that the 2-year postsurgical 
developmental outcomes of infants were best for the infants who underwent surgery when they 
were relatively young and who had the highest level of developmental performance 
presurgically, again supporting the idea that earlier intervention may halt epileptogenesis-related 
developmental deterioration. 
 We found no correlation between developmental outcome and underlying pathology, 
indicating that intellectual decline may not depend on the presence of specific underlying 
etiological factors, but may be the result of epilepsy itself. This contrasts with past follow-up and 
retrospective studies that have shown a subnormal IQ performance at entry into the study and no 
deterioration of IQ during the following years of epilepsy [1], [2], [19], [20] and [26]. Although 
the results of these other studies have been interpreted as suggesting that the underlying brain 
pathology is responsible for the cognitive deterioration associated with epilepsy, all of these 
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studies started assessing patients several years after the onset of epilepsy. Therefore, as 
suggested by Neyens [11], the absence of significant IQ loss during follow-up could be due to 
the fact that these studies evaluated patients during the stable phase after epilepsy onset, while 
the critical period might have been the years immediately subsequent to epilepsy onset [3]. 
 The results of our study are limited by our one-time point assessment. No longitudinal 
observations were included. To discern whether epilepsy itself and not the underlying pathology, 
such as MCD, is the major cause of developmental deterioration, a larger prospective control 
group with children with MCD without epilepsy would be needed. Thus, a recognized limitation 
of studies similar to ours is the lack of an appropriate control group. On the basis of our data, we 
cannot definitively determine whether the developmental delay is based on duration of epilepsy, 
age at epilepsy onset, underlying pathology, or an additional not-assessed factor. Data 
acquisition was purely retrospective and may not be representative of the general population of 
infants with epilepsy because we reviewed only data available at tertiary epilepsy centers with 
referral and ascertainment biases. As pediatric patients with epilepsy are not routinely provided 
neuropsychological evaluations, most of the patients included in this study were candidates for 
epilepsy surgery who received neuropsychological assessment as part of a routine presurgical 
evaluation. Rather, other young patients with epilepsy were referred for neurodevelopment 
assessment because of concerns about developmental delay, behavioral difficulties, specific 
cognitive problems, changes in developmental course, or altered neurobehavioral presentation. 
Of note, neuropsychological testing remains a source of limited availability and, at times, of 
limited demand. Thus, the main limitation of this study is related to the fact that patients with 
epilepsy and typical developmental progression often were not referred for evaluation and likely 
are not represented in our retrospective sample. In addition, test scores were incomplete for about 
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50% of patients initially included in the series, possibly further biasing the sample and leaving a 
small sample size that limits regression model analysis, a method of determining association that 
should not be confused with causal inference. As in our and others’ previous studies [9], [10], 
[11], [13] and [14], we used the hypothetical construct of the DQ to compare neuropsychological 
outcomes and relative duration of epilepsy in lifetime percent to compare infants of different 
ages with one another. Performance on the Bayley Scales of Infant and Toddler Development is 
essentially a sample of behavior under controlled conditions. As such, there is error involved in 
this type of behavioral measurement, and children with physical limitations may perform more 
poorly on the cognitive scale of the Bayley as motor output is often necessary for correct 
responding. Although a future prospective trial may deliver more precise results, a large number 
of patients would be necessary to compare different onset times of epilepsy as this variable 
cannot be controlled in human trials. Furthermore, recruitment of an appropriate control group 
may be quite challenging in this very young age group. 
 Taken together, these results suggest that earlier onset of epilepsy and longer relative 
duration of epilepsy lead to worse developmental outcome during infancy. These results are in 
line with the notion that early and aggressive intervention may lead to improved developmental 
outcome. However, our retrospective data set does not allow conclusions on possible direct 
effects of epilepsy and epileptogenesis on infant development. Further prospective, longitudinal 
and controlled evaluations are needed to evaluate whether early onset and long-standing epilepsy 
are detrimental to infantile brain development. 
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Table 1.  
Studies evaluating mental development in infants with epilepsy. 
Study n 
Age range 
(months) 
Time of 
follow-up 
Seizure 
type 
Treatment 
Neuropsychological 
testing during infancy 
Outcome 
Glaze et al. [7] 64 4–12 
44–
51 months 
Spasms 
and 
partial 
seizures 
ACTH  
Unspecified scales for IQ 
calculation 
Poor mental 
outcome at follow 
up 
Dulac et al. [6] 45 1–12 2–10 years 
Spasms 
and 
partial 
seizures 
ACTH, hydro-
cortisone, and 
valproate 
French Geselladaptationa 
Poor mental 
outcome at follow 
up in patients with 
persistent seizures 
Guzzetta et al. 
[9] 
31 2–18 2 years Spasms 
ACTH and 
multiple 
AEDs 
Bayley and Uzgiris–Hunt 
scales 
Variable 
Asarnow et al. 
[4] 
24 1–8 2 years Spasms Surgical 
Vineland adaptive 
behavior scales 
Better improvement 
at follow-up in 
younger infants 
Jambaque et al. 
[10] 
13 0.5–21 4–11 years 
Spasms 
and 
partial 
seizures 
Vigabatrin 
French Gesell adaptation, 
Terman Merrill and 
calculated DQ 
Improved 
development at 
follow-up 
Daniel et al. [14] 2 4–9 1–3.5 years 
Partial 
seizures 
Surgical 
Bartez scales and 
calculated DQ 
Improved 
development at 
follow up 
Jonas et al. [13] 55 1–50 
1.6–
2.2 years 
Spams Surgical 
Vineland adaptive 
behavior scales 
Improved 
development at 
follow up 
Loddenkemper 
et al. [11] 
24 3–33 
10–
53 months 
Spasms 
and 
partial 
seizures 
Surgical Bayley scales 
Improved 
development at 
follow up 
Guzzetta et al. 
[8] 
21 2–10 2–2.5 years Spasms 
ACTH, 
vigabatrin, 
and multiple 
AEDs 
Griffiths’ scales and 
general quotient (GQ) 
Variable 
Sharma and 
Vishwanthan 
[12] 
24 4–20 2 years Spasms ACTH 
Christian Medical 
College (CMC) 
developmental scale 
Improved 
development at 
follow up 
Bombardieri et 
al. [5] 
10 2–11 3–12 years 
Spasms 
and 
partial 
seizures 
Multiple 
AEDs 
Brunet-Lezine scale (BL) 
and calculated DQb 
Variable 
a Development assessed only at follow-up. 
b Development assessed only at follow-up in only one infant. 
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Table 2.  
Clinical characteristics of the 33 infants included in the study. 
ID Sex 
Age at epilepsy 
onset (months) 
Age at testing 
(months) 
DQ 
Epilepsy 
duration 
(months) 
Epilepsy 
duration (% 
lifetime) 
Pathology 
(MCD)a 
Type of seizure 
(epileptic spasms) 
1 M 0.9 4 0.5 3.07 77.32 + + 
2 M 2 22 0.58 20 90.90 − − 
3 M 0.1 3 0 2.9 96.66 + + 
4 M 1.5 3 0.32 1.53 50.49 + + 
5 M 3.5 19 0.57 15.47 81.54 − − 
6 M 0 3 0 3.53 100 − + 
7 M 1.5 16 0 14.37 90.54 − + 
8 M 0 18 0.43 18.4 100 + + 
9 M 12 32 0.54 20.87 63.49 + − 
10 F 4 8 0.35 4.37 52.21 + + 
11 M 1.5 18 0.39 16.4 91.62 − − 
12 F 1.5 4 0.66 3.07 67.17 − − 
13 F 0 3 0 3.1 100 + + 
14 M 15 18 0.92 3.27 17.89 + − 
15 F 6 19 0.56 13.2 68.75 − − 
16 M 0.15 12 0.23 12.52 98.81 + + 
17 M 1.5 13 0.45 11.47 88.43 + − 
18 F 0 8 0 8.1 100 − − 
19 M 0 5 0.34 5.77 100 + + 
20 M 0 9 0.54 9.03 100 + − 
21 F 10 25 0.87 15 60 + − 
22 M 0.1 10 0.09 10.57 99.06 + − 
23 M 0 7 0 7.6 100 − − 
24 M 0 4 0 4.27 100 − + 
25 M 5 18 0.27 13 72.22 + + 
26 F 12 26 0.66 14 53.84 − − 
27 M 5 29 0.27 24 82.75 + − 
28 M 18 22 1 4 18.18 + − 
29 F 0 29 0 29 100 + + 
30 F 9 31 0.5 22 70.96 − − 
31 F 6 30 0.33 24 80 − − 
32 F 12 28 0.66 16 57.14 + − 
33 F 0.1 9 0.22 8.9 98.88 + − 
a 
+, MCD; −, pathology other than MCD. 
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Table 3.  
Regression model with developmental outcome predictors. 
Predictor Coefficient estimate Confidence interval P value 
Age at epilepsy onset 0.04 (0.026, 0.054) <0.0001 
Percentage of life with epilepsy −0.09 (−0.007,−0.010) <0.0001 
Note. The model with age at epilepsy onset as the only predictor of DQ was highly significant (P < 0.0001), as was the 
model with percentage of life with epilepsy as the sole predictor (P < 0.0001). 
 
 
Fig. 1. Regression analysis coefficients for DQ and percentage of life with epilepsy and age at epilepsy onset. The direction of 
the regression coefficient indicates that the DQ rises with increasing age at epilepsy onset and decreasing percentage life with 
epilepsy. 
 
